Skip to main content
SpringerLink
Log in

Case Report: Is Catatonia a Clinical Feature of the Natural Progression of NLGN2-Related Neurodevelopmental Disorder?

  • Letter to the Editor
  • Published:
Journal of Autism and Developmental Disorders Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  • Baig, D. N., Yanagawa, T., & Tabuchi, K. (2017). Distortion of the normal function of synaptic cell adhesion molecules by genetic variants as a risk for autism spectrum disorders. Brain Research Bulletin, 129, 82–90.

    Article  Google Scholar 

  • Belligni, E. F., Di Gregorio, E., Biamino, E., Calcia, A., Molinatto, C., Talarico, F., et al. (2012). 790 Kb microduplication in chromosome band 17p13. 1 associated with intellectual disability, afebrile seizures, dysmorphic features, diabetes, and hypothyroidism. European Journal of Medical Genetics, 55(3), 222–224.

    Article  Google Scholar 

  • Berkel, S., Marshall, C. R., Weiss, B., Howe, J., Roeth, R., Moog, U., et al. (2010). Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nature Genetics, 42(6), 489.

    Article  Google Scholar 

  • Breckpot, J., Vercruyssen, M., Weyts, E., Vandevoort, S., D'Haenens, G., Van Buggenhout, G., et al. (2016). Copy number variation analysis in adults with catatonia confirms haploinsufficiency of SHANK3 as a predisposing factor. European Journal of Medical Genetics, 59(9), 436–443.

    Article  Google Scholar 

  • Cao, X., & Tabuchi, K. (2017). Functions of synapse adhesion molecules neurexin/neuroligins and neurodevelopmental disorders. Neuroscience Research, 116, 3–9.

    Article  Google Scholar 

  • Dong, H., Sharma, M., Zhou, H. X., & Cross, T. A. (2012). Glycines: Role in α-helical membrane protein structures and a potential indicator of native conformation. Biochemistry, 51(24), 4779–4789.

    Article  Google Scholar 

  • Egger, J. I., Verhoeven, W. M., Groenendijk-Reijenga, R., & Kant, S. G. (2017). Phelan-McDermid syndrome due to SHANK3 mutation in an intellectually disabled adult male: Successful treatment with lithium. Case Reports, 2017, bcr-2017.

  • Ellul, P., & Choucha, W. (2015). Neurobiological approach of catatonia and treatment perspectives. Frontiers in Psychiatry, 6, 182.

    Article  Google Scholar 

  • Hare, D. J., & Malone, C. (2004). Catatonia and autistic spectrum disorders. Autism, 8(2), 183–195.

    Article  Google Scholar 

  • Howell, B. W., & Smith, K. M. (2019). Synaptic structural protein dysfunction leads to altered excitation inhibition ratios in models of autism spectrum disorder. Pharmacological Research, 139, 207–214.

    Article  Google Scholar 

  • Kuroda, Y., Ohashi, I., Tominaga, M., Saito, T., Nagai, J. I., Ida, K., et al. (2014). De novo duplication of 17p13. 1–p13. 2 in a patient with intellectual disability and obesity. American Journal of Medical Genetics Part A, 164(6), 1550–1554.

    Article  Google Scholar 

  • Mooneyham, K. A., Holden, K. R., Cathey, S., Dwivedi, A., Dupont, B. R., & Lyons, M. J. (2014). Neurodevelopmental delays and macrocephaly in 17p13. 1 microduplication syndrome. American Journal of Medical Genetics Part A, 164(11), 2887–2891.

    Article  Google Scholar 

  • Parente, D. J., Garriga, C., Baskin, B., Douglas, G., Cho, M. T., Araujo, G. C., et al. (2017). Neuroligin 2 nonsense variant associated with anxiety, autism, intellectual disability, hyperphagia, and obesity. American Journal of Medical Genetics Part A, 173(1), 213–216.

    Article  Google Scholar 

  • Rapoport, J., Chavez, A., Greenstein, D., Addington, A., & Gogtay, N. (2009). Autism spectrum disorders and childhood-onset schizophrenia: Clinical and biological contributions to a relation revisited. Journal of the American Academy of Child & Adolescent Psychiatry, 48(1), 10–18.

    Article  Google Scholar 

  • Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J., & Kircher, M. (2019). CADD: Predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Research, 47(D1), D886–D894.

    Article  Google Scholar 

  • Schwarz, J. M., Cooper, D. N., Schuelke, M., & Seelow, D. (2014). MutationTaster2: Mutation prediction for the deep-sequencing age. Nature Methods, 11(4), 361–362.

    Article  Google Scholar 

  • Serret, S., Thümmler, S., Dor, E., Vesperini, S., Santos, A., & Askenazy, F. (2015). Lithium as a rescue therapy for regression and catatonia features in two SHANK3 patients with autism spectrum disorder. BMC Psychiatry, 15(1), 107.

    Article  Google Scholar 

  • Walton, J. R., & Coury, D. L. (2015). Medical comorbidities in autism spectrum disorder. In Clinician’s manual on autism spectrum disorder (pp. 33–41). Adis, Cham.

  • Wing, L., & Shah, A. (2000). Catatonia in autistic spectrum disorders. The British Journal of Psychiatry, 176(4), 357–362.

    Article  Google Scholar 

  • Yan, J., Oliveira, G., Coutinho, A., Yang, C., Feng, J., Katz, C., et al. (2005). Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. Molecular Psychiatry, 10(4), 329–332.

    Article  Google Scholar 

Download references

Acknowledgments

No grants or other financial support were utilized in preparation of this paper

Author information

Authors and Affiliations

  1. Cincinnati Children’s Hospital Medical Center Department of Human Genetics, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA

    Howard Saal

  2. Cincinnati Children’s Hospital Medical Center Department of Neurology, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA

    Marissa Vawter-Lee

  3. Cincinnati Children’s Hospital Medical Center Department of Psychiatry, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA

    Martine Lamy & Craig Erickson

  4. School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand

    Davide Comoletti

  5. Child Health Institute of New Jersey, Departments of Neuroscience and Cell Biology Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, USA

    Davide Comoletti

  6. Cincinnati Children’s Hospital Medical Center Department of Human Genetics, 3333 Burnet Rd, Cincinnati, OH, 45429, USA

    Amelle Shillington & Katherine Abell

Authors
  1. Amelle Shillington
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martine Lamy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marissa Vawter-Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Craig Erickson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Howard Saal
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Davide Comoletti
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Katherine Abell
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Material preparation was performed by AS. The first draft of the manuscript was written by AS, and all authors commented on previous versions of the manuscript. ML prepared the inpatient psychiatry management portion of the paper. Protein modeling studies were completed by DC. The protein modeling section of the paper was written by DC. Protein illustrations were completed by DC and KA. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Amelle Shillington.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Research Involving Human and Animal Rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed Consent

This article does not contain any identifying patient information including PHI or photographs, thus consent was not requested for publication.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shillington, A., Lamy, M., Vawter-Lee, M. et al. Case Report: Is Catatonia a Clinical Feature of the Natural Progression of NLGN2-Related Neurodevelopmental Disorder?. J Autism Dev Disord 51, 371–376 (2021). https://doi.org/10.1007/s10803-020-04531-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10803-020-04531-2

Search

Navigation